ArchPoint Investors’s Insmed INSM Stock Holding History

ArchPoint Investors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,000	Closed	-$40K	–	117
2018 Q3	$40K	Hold	2,000	–	–	0.01%	119
2018 Q2	$47K	Buy	+2,000	New	+$51.5K	0.01%	113

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

ArchPoint Investors's INSM Position: Q4 2018 in Review

ArchPoint Investors sold out of Insmed (INSM) in Q4 2018, closing a stake of 2,000 shares — an estimated $40K sold.

ArchPoint Investors first reported a position in INSM in Q2 2018 and held it in 2 quarters. The position peaked at $47K in Q2 2018. 126 funds tracked by Wall St. Rank hold INSM as of Q4 2018.

ArchPoint Investors reported no remaining Insmed position as of Q4 2018 after selling out during the quarter.
ArchPoint Investors sold 2,000 Insmed shares in Q4 2018, an estimated $40K.
ArchPoint Investors first reported a position in Insmed in Q2 2018 and held it in 2 quarters.
ArchPoint Investors's Insmed position peaked at $47K in Q2 2018.
126 funds tracked by Wall St. Rank held Insmed as of Q4 2018.

Based on ArchPoint Investors's 13F filing for Q4 2018, filed 14 Feb 2019.